Stryker Hip Lawsuit News: Number of Claims Filed in New Jersey Litigation Surpassed 2,000 in February, Bernstein Liebhard LLP Comments

Share Article

The Firm is representing numerous plaintiffs in Stryker hip lawsuits, all of whom allegedly suffered serious and debilitating complications due to recalled Rejuvenate and ABG II Modular Neck Hip Stems.

Free Case Review
“Our Firm is representing numerous individuals in this proceeding who allegedly suffered serious and debilitating complications due to the Rejuvenate and ABG II stems, and we look forward to continued progress in the coming months.

The Firm notes that thousands of Stryker hip lawsuits ( filed on behalf of individuals allegedly injured due to recalled Rejuvenate and ABG II hip stems are moving toward potential resolution in a multicounty litigation currently underway in New Jersey’s Bergen County Superior Court.

According to a new Case List issued by the Court on February 25, 2015, 2,204 complaints are now pending in the proceeding. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

This is of particular interest to the attorneys at Bernstein Liebhard LLP, who are representing numerous individuals whose lawsuits in Bergen County allege serious and debilitating complications due to the Rejuvenate and ABG II stems. “Our Firm is looking forward to continued progress in the coming months,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.

Stryker Hip Recall

According to court documents, the Stryker hip lawsuits pending in Bergen County were all filed in the wake of the July 2012 Rejuvenate and ABG II hip stem recall. The metal hip components were pulled from the market after data indicated they were associated with a high rate of fretting and corrosion at the modular neck junction. Stryker has warned that this occurrence puts recipients at risk for adverse local tissue reactions, pain and swelling. The company has recommended that anyone fitted with Rejuvenate and ABG II undergo medical testing and imaging screening to ensure their device is performing as intended, even if they have not experienced any symptoms that would suggest otherwise.*

In addition to the claims pending in New Jersey, nearly 2,300 Stryker lawsuits involving the Rejuvenate and ABG II recall have also been filed in a multidistrict litigation underway in U.S. District Court, District of Minnesota. Court records indicate that all of the lawsuits pending in this proceeding, as well as the litigation underway in New Jersey, accuse Stryker of manufacturing defective hip stems and of failing to adequately test the devices to ensure their safety. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)

A Stryker hip settlement program was announced in Bergen County Superior Court on November 3, 2014. According to court documents, the settlement could resolve all of the claims related to the Stryker hip recall currently pending in state and federal courts. The agreement provides for gross base awards of $300,000 per failed implant, with potential deductions and enhancements based on the particulars of each case, including additional compensation for claimants who suffered complications during revision surgery and for other damages, including future surgeries caused by complications. The settlement also provides compensation for individuals who need a revision but who are medically unable to undergo the surgery.

Individuals who were allegedly injured by Stryker’s recalled Rejuvenate and ABG hip stems may be entitled to compensation for medical bills, lost wages and other damages. To learn more, please visit Bernstein Liebhard LLP’s website. For a free and confidential evaluation of your case, call 800-511-5092 today.

* Stryker

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sandy A. Liebhard
Follow us on
Visit website